Stefano Vagge

Jun 15, 2023 | frontiersin.org | Takumi Kumai |Carryn M. Anderson |Stefano Vagge

IntroductionHead and neck cancer is a common malignancy, accounting for about 900,000 new cancer diagnoses annually worldwide (1) and 66,000 in the United States (2). Over the last two decades, data from randomized trials have changed the treatment paradigm for head and neck cancer, emphasizing organ preservation using concurrent chemoradiation (3, 4).